发明申请
US20110015219A1 (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
审中-公开
（+） - 吗啡喃作为Toll样受体9的拮抗剂及其治疗用途
- 专利标题： (+)-Morphinans as Antagonists of Toll-Like Receptor 9 and Therapeutic Uses Thereof
- 专利标题（中）： （+） - 吗啡喃作为Toll样受体9的拮抗剂及其治疗用途
-
申请号： US12837545申请日： 2010-07-16
-
公开(公告)号： US20110015219A1公开(公告)日： 2011-01-20
- 发明人: Bobby N. Trawick , David W. Berberich
- 申请人： Bobby N. Trawick , David W. Berberich
- 申请人地址： US MO Hazelwood
- 专利权人： Mallinckrodt Inc.
- 当前专利权人： Mallinckrodt Inc.
- 当前专利权人地址： US MO Hazelwood
- 主分类号： A61K31/485
- IPC分类号： A61K31/485 ; C07D221/28 ; C07D489/02 ; C07D489/08 ; C07D491/18 ; C07D217/20 ; A61K31/472 ; A61P29/00 ; A61P37/00 ; A61P35/00 ; A61P25/28 ; C12N5/071
摘要：
The present invention provides (+)-morphinans comprising Toll-like receptor 9 (TLR9) antagonist activity, as well as a method for identifying (+)-morphinans that may be therapeutically effective by determining whether the (+)-morphinan inhibits the activation of TLR9. Also provided are methods of using the (+)-morphinans comprising TLR9 antagonist activity to treat conditions such as traumatic pain, neuropathic pain, inflammatory disorders, acetaminophen toxicity, autoimmune disorders, neurodegenerative disorders, and cancer.
信息查询
IPC分类:
